Table 5.

Interactions between OBE and BMI (Continuous outcomes)

	OBE-BMI Interaction	Normal weight with OBE (n=18)	Normal weight NBE (n=1124)	Overweight with OBE (n=34)	Overweight NBE (n=1165)	Obese with OBE (n=120)	Obese NBE (n=838)
Metabolic Risk Factor	p	Adjusted mean	Adjusted mean	Adjusted mean	Adjusted mean	Adjusted mean	Adjusted mean
HDL Cholesterol	0.01	71.5 mg/dL	68.6 mg/dL	55.1 mg/dL	57.3 mg/dL	51.4 mg/dL	51.9 mg/dL
Log Triglycerides	0.04	4.2 mg/dL	4.3 mg/dL	4.6 mg/dL	4.6 mg/dL	4.8 mg/dL	4.8 mg/dL
VAT	0.01	863 cm3	1015 cm3	2209 cm3	2142 cm3	3312 cm3	3367 cm3
SAT	0.02	2226 cm3	2030 cm3	3353 cm3	3000 cm3	4996 cm3	4865 cm3
VAT HU	0.001	−85.5 HU	−87.5 HU	−94.2 HU	−94.1 HU	−99.0 HU	−99.1 HU
SAT HU	<0.0001	−103.5 HU	−103.6 HU	−106.2 HU	−106.5 HU	−108.7 HU	−108.1 HU
ALT	0.05	19.5 mg/dL	19.1 mg/dL	28.8 mg/dL	25.7 mg/dL	32.3 mg/dL	31.7 mg/dL
Liver Phantom Ratio	0.04	0.38	0.38	0.33	0.35	0.30	0.30

Only significant interactions shown. Interactions were not significant for systolic or diastolic blood pressure, total cholesterol, triglycerides, glucose, log HOMA-IR, VAT/SAT Ratio, AST or Framingham Risk Score

OBE = objective binge eating; NBE = non-binge eating; VAT = visceral adipose tissue; SAT = subcutaneous adipose tissue; HU = Hounsfield units; ALT = alanine aminotransferase; AST = aspartate aminotransferase; HOMA-IR = homeostatic model assessment for insulin resistance